A phase II trial of cisplatin, ifosfamide, and mesna in patients with advanced or recurrent uterine malignant mixed mullerian tumors with evaluation of potential molecular targets

By Ramondetta L.M.   Burke T.W.   Jhingran A.   Schmandt R.   Bevers M.W.   Wolf J.K.   Levenback C.F.   Broaddus R.  

Gynecologic Oncology, Vol. 90, Iss. 3, 2003-09 ,pp. : 529-536

Elsevier

Access to resources Recommend Favorite

Phase II study of liposomal doxorubicin and weekly paclitaxel for recurrent Mullerian tumors

By Campos S.M.   Matulonis U.A.   Penson R.T.   Lee H.   Berkowitz R.S.   Duska L.R.   Fuller A.F.   Wilson K.S.   Puchalski T.A.   Supko J.G.   Seiden M.V.  

Gynecologic Oncology, Vol. 90, Iss. 3, 2003-09 ,pp. : 610-618

Elsevier

Access to resources Recommend Favorite

Juvenile Granulosa Cell Tumors of the Ovary in Children and Adolescents: Results from 33 Patients Registered in a Prospective Cooperative Study

By Calaminus G.   Wessalowski R.   Harms D.   Gobel U.  

Gynecologic Oncology, Vol. 65, Iss. 3, 1997-06 ,pp. : 447-452

Elsevier

Access to resources Recommend Favorite

Detection of Tumor Circulating Cells by Cytokeratin-20 in the Blood of Patients with Granulosa Cell Tumors

By Altaras M.M.   Klein A.   Zemer R.   Zimlichman S.   Bernheim J.   Fishman A.  

Gynecologic Oncology, Vol. 86, Iss. 3, 2002-09 ,pp. : 330-336

Academic Press

Access to resources Recommend Favorite

Management of Recurrent Juvenile Granulosa Cell Tumor of the Ovary

By Powell J.L.   Connor G.P.   Henderson G.S.  

Gynecologic Oncology, Vol. 81, Iss. 1, 2001-04 ,pp. : 113-116

Elsevier

Access to resources Recommend Favorite